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ABSTRACT
Paragangliomas are rare neuroendocrine tumors. The most common site is the adrenals cervical region. Cervical paragangliomas 
are divided into carotid body and vagus types. Here, we report the case of a non-functional cervical paraganglioma in a 78-year-
old male came with complaints of swelling in the left side of the neck for 2 years. On imaging, guided core needle biopsy showed 
eosinophilic cells with vacuolated nuclei and some inclusion bodies which suggested a possible clear cell tumor, neuroendocrine 
tumor or a paraganglioma. Complete surgical excision was done under general anesthesia, postoperative histopathology and 
immunohistochemistry markers (S100, Synaptophysin, and Ki67) suggested of paraganglioma.
Keywords: Non-functional, Paraganglioma, Surgical excision, Vagal.
Paragangliomas are rare, vascular, neuroendocrine tumor arise from the neural crest cells. The annual incidence of paragangliomas is 3-8 cases per 1 million population per 
year, which comprises 0.6% of all head and neck tumors1,2. They 
may be functional (catecholamine secreting) or non-functional. 
Functional tumors show an abundance of extra-adrenal 
chromaffin stained cells. The most common site for extra-adrenal 
paragangliomas is head and neck. Head and neck paragangliomas 
are divided into vagal nerve (Xth nerve) and carotid body types. 
Surgery of these tumors remain the mainstay of treatment, 
radiotherapy can be tried as adjuvant therapy [1,3]. We present 
the case of a non-functional cervical paraganglioma in a 78-year-
old male. We are reporting this case in view of its rarity in the 
incidence.
CASE REPORT
A 78-year-old male presented with complaints of swelling in the 
left side of the neck for 2years. Swelling rapidly increased in size 
in the past 6 months. There were no other complaints of pain 
fever, any other swellings. There was no history for any neural 
deficit, hypertension, diabetes mellitus, and tuberculosis. There 
were no bowel and bladder disturbances. 
On examination, patient general condition and vitals were 
found to be stable. On local examination of the neck, a 14x10 
cms swelling was noticed in the posterior triangle (Fig. 1). The 
swelling was smooth surfaced, hard in consistency and skin over 
the swelling appeared normal. 
The computed tomography (CT) imaging revealed a hypodense 
lesion with hypervascularity in the posterior triangle abetting 
the sternocleidomastoid muscle and the trapezius muscle with 
no infiltration into any vital structures (Fig. 2). An ultrasound-
guided core needle biopsy was done which showed eosinophilic 
cells with vacuolated nuclei and some inclusion bodies which 
suggested a possible clear cell tumor, neuroendocrine tumor or 
a paraganglioma. 
Under general anesthesia, the patient was taken up for 
complete surgical excision of the tumor (Fig. 3). Postoperatively, 
the patient did not have any complaints of swallowing difficulties 
or any neural deficit. On histopathological examination and 
immunohistochemistry marker study of the postoperative 
specimen, it was seen positive for S100, Synaptophysin, and Ki67 
suggesting a paraganglioma (Fig. 4). On a one month follow-up, 
the patient was comfortable and asymptomatic.
DISCUSSION
Kohn coined the term ‘paraganglioma’ in the year 1900. They may 
be inherited or sporadic [3]. In the case of familial paragangliomas, 
they are inherited in an autosomal dominant manner. They can be 
seen along with hereditary syndromes such as PGL1, PGL3, and 
PGL4 which occur due to mutations in SDHD, SDHC, SDHB 
genes respectively, whereas PGL2 syndrome has no specific 
mutation [3,4]. Usually, they are benign in 85-95% of the cases 
[4]. Till now, 93 cases of paragangliomas were reported to have 
a malignant transformation in the USA [1] as these tumors are 
generally locally aggressive with rare distant metastasis. An 
estimated mean growth time for paraganglioma is 1.0mm/
year and a mean doubling time of 4.2 years [2,4]. WorldHealth 
Organization (WHO) classified them as intra-adrenal and extra-
adrenal tumors. In extra-adrenal head and neck are the common 
sites. They constitute to about 0.6% of all head and neck tumors.
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Head and neck paragangliomas are broadly divided into vagal 
and carotid body types. Netterville classification and Shambin 
classification can be used for further classifying vagal and carotid 
body tumors respectively [4]. Netterville classification classifies 
them as type A(tumor confined to neck), type B (tumor in contact 
with jugular foramen) and type C (tumor penetrating into or 
extending beyond jugular foramen with or without intracranial 
extension). Shamblin classification classifies these tumors as 
type I (not involving carotid artery), type II (partially involving 
internal carotid artery or carotid body), type IIIA (completely 
involving internal carotid artery or carotid body with no skull 
base contact) and type IIIB (completely involving internal 
carotid artery or carotid body with contact to skull base) [4]. The 
differential diagnosis for this condition is pheochromocytoma, 
atypical carcinoid of the larynx, alveolar soft part sarcoma, 
melanoma, glomus tumors.
Paragangliomas are generally solitary and present in the 5th 
decade of life. The youngest case reported was of 5years age [5]. 
They are found to be multicentric in 30-40% of familial cases and 
10% of sporadic cases [1]. Clinically, paragangliomas are divided 
into functional and non-functional tumors, 4% of tumors are also 
reported to be hyperfunctional [6]. Functional tumors present with 
features of hypertension, headache, palpitation, fever, pallor, dyspnea, 
vomiting, dizziness, flushing, seizures and paraesthesias, whereas, 
non-functional tumors are generally found incidentally or may present 
as slow-growing tumors [3]. Approximately, 30% of vagal tumors and 
2% of carotid body tumors may present with nerve deficit also [4].
On ultrasonogram, they are seen as heterogeneous, 
hypoechoic, hypervascular lesions and on contrast-enhanced 
computed tomography (CECT), they appeared as hypodense 
lesions with rapid, intense contrast enhancement and early 
venous washout. Carotid body type tumors show a characteristic 
lyre appearance on CT [4]. Magnetic resonance imaging (MRI) 
would be the standard imaging modality for paragangliomas, in 
which they are seen as hypo or isointense lesions on T1 weighted 
images and hyperintense on T2 weighted images [7,8]. MRI 
angiography can be done to evaluate for vascular displacement [8]. 
Core needle biopsy would show two types of cells: type 1 shows 
catecholamine granules and type 2 cells similar to Schwann 
cells [1]. On immunohistochemistry, staining these tumors stain 
positive for CD56, synaptophysin, chromogranin, NSE, S100 and 
negative for Keratin, EMA, mucin, CEA, TTF1, HMB45 [9].
The various treatment modalities used for paragangliomas 
are surgery, radiotherapy, wait and watch methods, with surgery 
Figure 1: Swelling in the lateral aspect of the neck Figure 2: CT image showing the swelling
Figure 3: (a) The intraoperative picture; (b) bed of the tumor
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being the standard treatment for these. But, each case should 
be individualized before taking up for any treatment [2,3,7]. 
Complete surgical excision of the tumor would give a cure 
rate of 89-100% [2]. In case of functional tumors, alpha and 
beta blockers are given to counter with hypertension prior to 
surgery [3]. A preoperative embolization can also be tried 2-3 
days prior to surgery to reduce the intraoperative bleeding [4]. 
Lymphadenectomy is generally not done but in case of lymph 
node metastasis, regional lymphadenectomy can be done. 
Approximately, 60-80% of cases have swallowing difficulties 
in the immediate postoperative period, but only 14% of cases 
have a permanent postoperative morbidity [4] and 30% of the 
cases have a recurrence even after complete surgical excision 
[3]. Gamma knife and Cyberknife radiotherapy are given 
in cases of large, non-resectable tumors as an alternative 
to reduce the tumor load and to make the tumor resectable 
[2,4]. Henerman et.al quoted96-100% tumor control by 
radiotherapy with a dose of 45Gy2. There is no possible 
evidence in support of postoperative radiotherapy. Tumors 
which are nearby large vessels or important structures and are 
non-resectable can be waited and watched as the mortality rate 
in non-treated cases with age more than 70 years is less than 
10% [4]. Some authors also suggest palliative chemotherapy 
by cyclophosphamide, dacarbazine, and vincristine in cases 
of non-resectable tumors [3].
CONCLUSION
Cervical paragangliomas are very rare tumors and difficult to 
diagnose. Surgical excision is the treatment of choice. 
REFERENCES
1. Almeida FS, Gomes OJ, Silva A, Pialarissi PR. Carotid Body Paraganglioma: 
Case Report. Int Arch Otorhinolaryngol 2007;11:207-13.
2. Kollert M, Minovi AA, Draf W, Bockmühl U. Cervical paragangliomas-
tumor control and long-term functional results after surgery. Skull Base 
2006;16:185-91.
3. Balasubramanian G, Nellaiappan V. Functional paraganglioma. BMJ Case 
Rep 2014.doi:10.1136/bcr-2013-203425.
4. Makeieff J, Thariat E, Reyt C.A, Righini M. Treatment of cervical 
paragangliomas. European Annals of Otorhinolaryngology 2012;129, 
308-14.
5. S Saha, Pk Mondal, S Misra, N Basu, A Basu, S Das, Sk Sinha. Paraganglioma 
of Neck in a Child-A Case Report. J Indian Assoc Pediatr Surg 2002;7: 
199-202.
6. Dana Erickson, Yogish C. Kudva, Michael J. Ebersold, Geoffrey B. 
Thompson, Clive S. Grant, Jon A. Van Heerden, William F. Young. 
Benign Paragangliomas: Clinical Presentation and Treatment Outcomes 
in 236 Patients. The Journal of Clinical Endocrinology & Metabolism 
2001;86:5210-6.
7. Neves F, Huwart L, Jourdan G, Reizine D, Herman P, Vicaut E, Guichard 
JP. Head and neck paragangliomas: the value of contrast-enhanced 3D MR 
angiography. AJNR Am J Neuroradiol 2008;29:883-9. 
8. Cristina Capatina, Georgia Natali, Niki Karavitaki, Ashley B Grossman. 
The management of head-and-neck Paraganglioma. Endocr Relat Cancer 
2013;20:R291-R305.
9. Martin TPC, Irving RM, Maher ER. The genetics of paragangliomas: a 
review. Clin Otolaryngol 2007;32:7-11.
Funding: None; Conflict of Interest: None Stated.
How to cite this article: Balineni P, Pathivada1 S, Merlin SD, Kamal S. Non-
functional cervical paraganglioma in an adult: A case report. Indian J Case 
Reports. 2019;5(2):171-173.
Doi: 10.32677/IJCR.2019.v05.i02.026
Figure 4: The histopathological slide with eosinophilic cells and 
vacuolated nuclei
